Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer

International Journal of Cancer

Volumn 70, Issue 2, 1997, Pages 183-187

  Hall, Simon J ^a   Mutchnik, Steven E ^a   Chen, Shu Hsia ^a   Woo, Savio L C ^a   Thompson, Timothy C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; ANTINEOPLASTIC AGENT; GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOVIRIDAE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; DEFECTIVE VIRUSES; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0031027728     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970117)70:2<183::AID-IJC8>3.0.CO;2-T     Document Type: Article

References (29)

1. BALEY, P.A., YOSHIDA, K., QIAN, W., SEHGAL, I. and THOMPSON, T.C., progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer. J. Steroid Biochem. mol. Biol., 52, 403-413 (1995).
2. BARBA, D., HARDIN, J., SADELAW, M. and GAGE, F.H., Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. nat. Acad. Sci. (Wash.), 91, 4348-4352 (1994).
3. BONNEKOH, B., GREENHALGH, D.A., BUNDMAN, D.S., ECKHARDT, J.N., LONGLEY, M.A., CHEN, S.-H., WOO, S.L.C. and ROOP, D.R., Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo. J. invest. Dermatol., 104, 313-317 (1995).
4. BOVIATSIS, E.J., PARK, J.S., SENA-ESTEVES, M., KRAMM, C.M., CHASE, M., EFIRD, J.T., WEI, M.X., BREAKFIELD, X.O. and CHIOCCA, E.A., Long-term survival of rats harboring brain neoplasms treated with gamaclorir and a herpes simplex virus ?? that retains an intact thyridine kinase gene. Cancer Res., 54, 5745-5751 (1994).
5. CHEN, S.-H., CHEN, X.H.L., WANG, Y., KOSAI, K.-I., FINEGOLD, M.J., RICH, S.S. and WOO, S.L.C., Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. nat. Acad. Sci. (Wash.), 92, 2577-2581 (1995).
6. CHEN, S.-H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G. and WOO, S.L.C., Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. nat. Acad. Sci. (Wash.), 91, 3054-3057 (1994).
7. COOL, V., PIROTTE, B., GERARD, C., DARGENT, J.-L., BAUDSON, N., LEVIVIER, M., GOLDMAN, S., HIDEBRAND, J., BROTCHI, J. and VELU, T., Curative potential of herpes simplex virus thymidine kinase gene transfer in rat with 9L gliosarcoma. Hum. Gene Ther., 7, 627-635 (1996).
8. EASTHAM, J.A., CHEN, S.-H., SEHGAL, I., YANG. G., TIMME. T.L., HALL, S.J., WOO, S.L.C. and THOMPSON, T.C., Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum. Gene Ther., 7, 515-523 (1996).
9. ELSHAMI, A.A., KUCHARCZUK, J.C., ZHANG, H.B., SMYTHE. W.R., HWANG, H.C., LITZKY, L.A., KAISER, L.R. and ALEBELDA. S.M., Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene. Hum. Gene Ther., 7, 141-148 (1996).
10. FIDLER, I.J., Critical factors in the biology of human cancer metastasis. Cancer Res., 50, 6130-6138 (1990).
11. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L. and ABRAHAM, G.N., The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53, 5274-5283 (1993).
12. FREEMAN, S.M., RAMESH, R., SHASTRI, M., MUNISHI, A., JENSEN, A.K. and MARROGI, A.J., The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells. Cancer Lett., 92, 167-174 (1995).
13. FROST, P., ROSE, N.R. and CHOE, B.-K., Immunology of prostate carcinoma - an overview. Semin. Oncol. 3, 107-113 (1976).
14. GITTES, R.F. and MCCULLOUGH, D.L., Occult carcinoma of the prostate: an oversight of immune surveillance - a working hypothesis. J. Urol., 112, 241-244 (1974).
15. GRAHAM, F. and PERVEC, L., Manipulation of adenoviraj vectors. In: E.J. Murray (ed.) Methods in molecular biology: gene transfer and expression protocols, Humana Press. Clifton, NJ (1991).
16. JANIK, P., BRIAND, P. and HARTMANN, N.R., The effect of estroneprogesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res., 35, 3698-3704 (1975).
17. MOOLTEN, F.L., Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control study. Cancer Res., 46, 5276-5281 (1986).
18. OHORI, M., WHEELER, T.M., KATTAN, M.W., GOTO, V. and SCARDINO, P.T., Prognostic significance of positive surgical margins in radical prostatectomy specimens. J. Urol., 154, 1818-1824 (1995).
19. O'MALLEY, B.W., JR., CHEN, S.-H., SCHWARTZ, M.R. and WOO, S.L.C., Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res., 55, 1080-1085 (1995).
20. O'REILLY, M.S., HOLMGREN, L., SHING, Y., CHEN, C., ROSENTHAL, R.A., MOSES, M., LANE, W.S., CAO, Y., SAGE, E.H. and FOLKMAN, J., Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (1994).
21. PARKER, S.L., TONG, T., BOLDEN, S. and Wingo, P.A., Cancer statistics, 1996. CA Cancer J. Clin., 46, 5-27 (1996).
22. PEREZ-CRUET, M.J., TRASK, T.W., CHEN, S.-H., GOODMAN, J.C., WOO, S.L.C., GROSSMAN, R.G. and SHINE, H.D., Adenovirus-mediated gene therapy of experimental gliomas. J. Neurosci. Res., 39, 506-511 (1994).
23. RAM, Z., WALBRIDGE, S., SHAWKER, T., CULVER, K.W., BAESE, R.M. and OLDFIELD, E.H., The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurg., 81, 256-260 (1994).
24. STRATFORD-PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M. and BRIAND, P., Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest., 90, 626-630 (1992).
25. THOMPSON, T.C., SOUTHGATE, J., KITCHENER, G. and LAND, H., Multi-stage carcinogenesis induced by ras and myc oncogenes in a reconstituted model. Cell, 56, 917-930 (1989).
26. VIEWEG, J., ROSENTHAL, P.M., BANNERJI, R., HESTON, W.D.W., FAIR, W.R., GANSBACHER, B. and GILBOA, E., Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res.,54, 1760-1765 (1994).
27. VILE, R.G., NELSON, J.A., CASTLEDEN, S., CHONG, H. and HART, I.R., Systemic gene therapy of murfne melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res., 54, 6228-6234 (1994).
28. WEIDNER, N., CARROLL, P.R., FLAX, J., BLUMENFIELD, W. and FOLKMAN, J., Tumor angiogenesis correlates with metastasis in invasive prostate cancer. Amer. J. Pathol., 143, 401-409 (1993).
29. ZEITMAN, A.L., EDELSTEIN, R.A., COEN, J.J., BABAYAN, R.K. and KRANE, R.J., Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical diseasefree outcome. Urology, 43, 828-833 (1994).